InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
2
T+90 hit rate
100%
T+90 mean return
+3.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Hussain Iqbal J, Directeur Juridique. Director active across 1 company, notably Centessa Pharmaceuticals plc. Cumulatively, 32 filings have been published. Split: 1 buy · 2 sells. Total volume traded: €86k. History available since 2 June 2021. The latest transaction was disclosed on 30 January 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Hussain Iqbal J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
117,645 sharesOrdinary SharesSEC:0001470831-26-000622:0
5,500 sharesOrdinary SharesSEC:0001470831-26-000622:1
1,010 shares@ US$25.01091.6% of flowOrdinary SharesSEC:0001470831-26-000092:0
6,000 shares@ US$5.842.3% of flowOrdinary SharesSEC:0001470831-25-000344:0
6,000 shares@ US$5.840.0005% mcap19.0% of flowOrdinary SharesSEC:0001470831-25-000263:0
6,000 shares@ US$5.842.3% of flowOrdinary SharesSEC:0001470831-25-000200:0
20,000 shares@ US$5.847.9% of flowOrdinary SharesSEC:0001470831-25-000189:0
6,000 shares@ US$5.842.6% of flowOrdinary SharesSEC:0001847903-25-000137:0
6,000 shares@ US$5.842.6% of flowOrdinary SharesSEC:0001847903-25-000117:0
12,000 shares@ US$5.845.4% of flowOrdinary SharesSEC:0001847903-25-000114:0
311 shares@ US$5.840.1% of flowOrdinary SharesSEC:0001847903-25-000064:0
3,609 shares@ US$5.841.6% of flowOrdinary SharesSEC:0001847903-25-000061:0
6,000 shares@ US$5.842.9% of flowOrdinary SharesSEC:0001847903-25-000040:0
6,000 shares@ US$5.843.0% of flowOrdinary SharesSEC:0001847903-25-000033:0
12,879 shares@ US$16.9218.6% of flowOrdinary SharesSEC:0001847903-25-000025:0
6,000 shares@ US$5.843.0% of flowOrdinary SharesSEC:0001847903-25-000009:0
7,520 shares@ US$16.3510.5% of flowOrdinary SharesSEC:0001847903-24-000200:0
6,000 shares@ US$5.843.0% of flowOrdinary SharesSEC:0001847903-24-000183:0
7,520 shares@ US$15.799.4% of flowOrdinary SharesSEC:0001847903-24-000156:0
7,520 shares@ US$9.035.6% of flowOrdinary SharesSEC:0001847903-24-000118:0
7,520 shares@ US$11.307.0% of flowOrdinary SharesSEC:0001847903-24-000061:0
42,500 shares0Ordinary SharesSEC:0001847903-24-000035:0
7,520 shares@ US$7.964.8% of flowOrdinary SharesSEC:0001847903-24-000015:0
7,520 shares@ US$6.474.1% of flowOrdinary SharesSEC:0001847903-23-000179:0
7,104 shares@ US$5.90013.4% of flowOrdinary SharesSEC:0001847903-23-000145:0
25 of 32 declarations
About Hussain Iqbal J
HUSSAIN IQBAL J is Directeur Juridique and Chief Legal Officer at Centessa Pharmaceuticals plc (XNAS). He has 32 filings, and across the 32 recent filings sampled, the cumulative amounts are EUR 49141 for buys and EUR 36525 for sells, with Levée d'options as the most common transaction nature, over the period from 2021-06-04 to 2026-06-24.
